Category Archives: The IPO Buzz

Last week was not a banner one for IPOs. Twelve companies went public with mixed results. Four IPOs finished their opening day as winners, six as losers and the other two were unchanged. The bio-IPO sector gave us a couple of noteworthy pops and flops. Their performance should not have surprised anyone. It was all right there in their respective prospectuses.

 

Last week’s best-performing IPO, OncoMed Pharmaceuticals (OMED ), started trading 65.6 percent above its initial offering price. This should not have come as a surprise. The clue to this biotech IPO’s winning performance can be found on the cover of its prospectus. This week’s calendar has a few more IPOs sending the same signal. All you have to do is look.

 

 

The IPO market exploded out of the U.S. Securities and Exchange Commission’s filing window with the fury of a summer storm. Starting last Monday, five companies filed plans to go public, 15 companies updated their previous filings and 14 IPOs hit the calendar. That’s not bad for the dog days of summer.

 

 

With one eye on the stock market and the other on the U.S. Securities and Exchange Commission’s filing window, the IPO calendar sits in wait for 2013’s second half to begin.

 

The IPO market closed out the year’s first half with blazing guns. In June’s final week, bankers priced 11 IPOs. And there was more. On Friday, the last trading day of the month, the Street witnessed a rare event – an opening-day IPO moonshot. That’s when an IPO explodes for a gain of 100 percent or more. What a way to head into the traditional July 4^th holiday!

 

With one eye on the ticker tape and the other on Washington, D.C., the IPO market cruises into June’s final week. It has an ambitious calendar of nearly a dozen offerings in the first full trading week of summer. And it’s looking at what could be an interesting stock market.

 

June’s IPO market is busting out all over. Eleven companies filed plans to go public last week; another 11 filed updated amendments, and eight of those 11 jumped on the IPO calendar with pricing dates. This week, six companies expect to price their IPOs. A year ago, the June 2012 calendar produced only four IPOs.

 

When a cloud floats over Wall Street these days, people hope it is an IPO. This week, they get their wish. A cloud-based IPO tops the coming calendar.

 

 

The legendary mountain man who roamed the Rocky Mountains in the early to mid-1800s lived by his wits and by reading the signs of nature. The hoot of an owl, the rustle of leaves, the color of the sky all told him something – much like reading the preliminary prospectuses in today’s IPO market. This week’s calendar tells us something.